The Global Health Body Raises Alert Over Severe Shortage of Obesity Medications
Under one in 10 people that would benefit from weight-loss injections such as Wegovy can access them, states the World Health Organization as it issues its inaugural advice on the medications.
Given in excess of 1,000,000,000 people worldwide now classified as obese, it is calling for more widespread and fairer availability to GLP-1 medication.
According to forecasts, in excess of 2,000,000,000 are projected to be obese by 2030 without intervention.
"Our latest guidelines affirms that excess weight is a lifelong illness that can be addressed with thorough and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.
Significant expense, insufficient output, and logistical bottlenecks are significant obstacles to broad access to the injections that can assist patients in reducing considerable weight, explains the organization.
Skinny Jab Supply Crisis
Despite the current best projected case, the production of these medications would only suffice for around 100 million people – less than 10% of the global need, per the WHO.
The recommendation calls on governments and firms to increase access, by measures such as patent sharing.
Exclusive production rights on a key compound – the main ingredient of a leading brand – is scheduled to end in several nations in 2026.
How Weight-Loss Jabs Operate
These medications replicate a biological compound to reduce digestion speed, suppress the appetite and boost satiety so individuals consume fewer calories.
Individuals usually begin shedding pounds after several weeks of beginning the regular doses.
Studies suggests people may put most of the weight back on after a year of discontinuing the treatment, as their typical food cravings resume.
Being carrying excess weight elevates your chance for developing health problems, like diabetes, cardiovascular issues, stroke, and specific cancers.
Obesity affects people in countries worldwide and was associated with 3.7 million fatalities worldwide in 2024, per the WHO.
